His primary areas of investigation include Immunology, Internal medicine, Virology, Acquired immunodeficiency syndrome and Virus. His research related to Immunopathology, Viral disease, Antigen, Lymphocyte and T cell might be considered part of Immunology. His research integrates issues of Gastroenterology and Surgery in his study of Internal medicine.
His Virology research is multidisciplinary, relying on both Efavirenz, CD8 and Genetic enhancement. His Acquired immunodeficiency syndrome study integrates concerns from other disciplines, such as Epidemiology, Circulating MicroRNA, microRNA and Case-control study. His work deals with themes such as Peripheral blood mononuclear cell, B cell and Toxoid, which intersect with Virus.
Ronald T. Mitsuyasu mainly focuses on Immunology, Internal medicine, Acquired immunodeficiency syndrome, Oncology and Virology. Immune system, Immunopathology, Virus, Viral disease and Antigen are subfields of Immunology in which his conducts study. His Internal medicine research incorporates themes from Gastroenterology and Surgery.
His research integrates issues of Clinical trial, Incidence, Sarcoma and Pathogenesis in his study of Acquired immunodeficiency syndrome. Ronald T. Mitsuyasu has included themes like Cetuximab, Chemotherapy regimen, Anal canal, Lymphoma and Radiation therapy in his Oncology study. His Virology research is multidisciplinary, relying on both Interleukin 2 and CD8.
Ronald T. Mitsuyasu focuses on Internal medicine, Oncology, EPOCH, Lymphoma and Rituximab. Internal medicine is often connected to Viral load in his work. His research in Oncology intersects with topics in Cetuximab, Anal canal, Immunology, Immune system and Radiation therapy.
His Immunology study often links to related topics such as Graft-versus-host disease. His biological study spans a wide range of topics, including Virology and AIDS-Related Non-Hodgkin Lymphoma. His Cancer study combines topics from a wide range of disciplines, such as Hiv epidemic, Acquired immunodeficiency syndrome, Body mass index and Paclitaxel carboplatin.
Ronald T. Mitsuyasu spends much of his time researching Internal medicine, EPOCH, Oncology, Lymphoma and Treatment interruption. His studies deal with areas such as Gastroenterology and Surgery as well as Internal medicine. Ronald T. Mitsuyasu combines subjects such as Cranial Irradiation and Chemotherapy with his study of Lymphoma.
His Treatment interruption research is multidisciplinary, incorporating perspectives in Peripheral blood mononuclear cell, Genome and CD8, Immune system. The concepts of his Young adult study are interwoven with issues in Record linkage, Cervical cancer, Cancer registry and Acquired immunodeficiency syndrome. His Cancer study integrates concerns from other disciplines, such as Proportional hazards model, Immunology, Cohort and Hazard ratio.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection : a case control study
Daniel D. Murray;Kazuo Suzuki;Matthew Law;Jonel Trebicka.
PLOS ONE (2015)
Dual infection of the central nervous system by AIDS viruses with distinct cellular tropisms.
Yoshio Koyanagi;Steven Miles;Ronald T. Mitsuyasu;Jean E. Merrill.
Effect of Recombinant Human Granulocyte–Macrophage Colony-Stimulating Factor on Myelopoiesis in the Acquired Immunodeficiency Syndrome
Jerome E. Groopman;Ronald T. Mitsuyasu;Michael J. DeLeo;Dagmar H. Oette.
The New England Journal of Medicine (1987)
Infection with HIV is associated with elevated IL-6 levels and production.
E C Breen;A R Rezai;K Nakajima;G N Beall.
Journal of Immunology (1990)
Decade-Long Safety and Function of Retroviral-Modified Chimeric Antigen Receptor T Cells
John Scholler;Troy L. Brady;Gwendolyn Binder-Scholl;Wei-Ting Hwang.
Science Translational Medicine (2012)
AIDS Kaposi sarcoma-derived cells produce and respond to interleukin 6.
S A Miles;A R Rezai;J F Salazar-González;M Vander Meyden.
Proceedings of the National Academy of Sciences of the United States of America (1990)
Prolonged survival and tissue trafficking following adoptive transfer of CD4ζ gene-modified autologous CD4+ and CD8+ T cells in human immunodeficiency virus–infected subjects
Ronald T. Mitsuyasu;Peter A. Anton;Steven G. Deeks;David T. Scadden.
Initial increase in blood CD4+ lymphocytes after HIV antiretroviral therapy reflects redistribution from lymphoid tissues
R. Pat Bucy;Richard D. Hockett;Cynthia A. Derdeyn;Michael S. Saag.
Journal of Clinical Investigation (1999)
Interleukin-2 therapy in patients with HIV infection.
D. Abrams;Y. Lévy;M. H. Losso;A. Babiker.
The New England Journal of Medicine (2009)
Recombinant alpha-2 interferon therapy for Kaposi's sarcoma associated with the acquired immunodeficiency syndrome
Jerome E. Groopman;Michael S. Gottlieb;Jesse Goodman;Ronald T. Mitsuyasu.
Annals of Internal Medicine (1984)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: